All Stories

  1. High-Intensity Interval Exercise Drives Vitamin D Receptor Expression in Skeletal Muscle via Recruitment of Non-Parenchymal Cells, Not Upregulation in Muscle Fibers
  2. Provocative testing in community dwelling older adults: a path to identify physical resilience
  3. Effects of a 6-Week Treadmill Training With and Without Virtual Reality on Frailty in People With Multiple Sclerosis
  4. Frailty in multiple sclerosis: A scoping review
  5. VO2MAX, 6-minute walk, and muscle strength each correlate with frailty in US veterans
  6. Age‐related increase of CD38 directs osteoclastogenic potential of monocytic myeloid‐derived suppressor cells through mitochondrial dysfunction in male mice
  7. Multimodal Exercise Training to Reduce Frailty in People with Multiple Sclerosis: Study Protocol for a Pilot Randomized Controlled Trial
  8. Multimodal exercise training to reduce frailty in people with multiple sclerosis: study protocol for a pilot randomized controlled trial
  9. The Relationships between Caregiver Burden, Physical Frailty, Race, Behavioral and Psychological Symptoms (BPSD), and Other Associated Variables: An Exploratory Study
  10. Proline restores mitochondrial function and reverses aging hallmarks in senescent cells
  11. Tristetraprolin regulates the skeletal phenotype and osteoclastogenic potential through monocytic myeloid‐derived suppressor cells
  12. Methionine adenosyltransferase2A inhibition restores metabolism to improve regenerative capacity and strength of aged skeletal muscle
  13. Inhibition of glutaminolysis restores mitochondrial function in senescent stem cells
  14. Tristetraprolin limits age-related expansion of myeloid-derived suppressor cells
  15. World guidelines for falls prevention and management for older adults: a global initiative
  16. HIIT, Sleep and Cognition in Older Adults
  17. Leukotriene inhibitors with dexamethasone show promise in the prevention of death in COVID-19 patients with low oxygen saturations
  18. Front Matter
  19. Frailty: The end of the osteosarcopenia continuum?
  20. Both Vitamin D Supplementation and HIIT Boost Muscle VDR Expression, Which May Underlie Benefits for Frailty
  21. Ameliorating the hallmarks of cellular senescence in skeletal muscle myogenic progenitors in vitro and in vivo
  22. Short-term nicotinamide riboside treatment improves muscle quality and function in mice and increases cellular energetics and differentiating capacity of myogenic progenitors
  23. Falls: To D or Not to D—That Is Not the (Only) Question!
  24. The Association of Muscle Mass Measured by D3-Creatine Dilution Method With Dual-Energy X-Ray Absorptiometry and Physical Function in Postmenopausal Women
  25. Pinpointing a Role for Vitamin D in Frailty: A Time for Animal Models?
  26. SRT2183 and SRT1720, but not Resveratrol, Inhibit Osteoclast Formation and Resorption in the Presence or Absence of Sirt1
  27. Vitamin D Insufficiency Reduces Grip Strength, Grip Endurance and Increases Frailty in Aged C57Bl/6J Mice
  28. Absence of complement factor H reduces physical performance in C57BL6 mice
  29. Racial Disparities in a Sample of Inpatient Youth with ASD
  30. AGS and NIA Bench‐to Bedside Conference Summary: Osteoporosis and Soft Tissue (Muscle and Fat) Disorders
  31. Investigating and Remediating Selection Bias in Geriatrics Research: The Selection Bias Toolkit
  32. High intensity interval training improves physical performance in aged female mice: A comparison of mouse frailty assessment tools
  33. Treatment with an inhibitor of fatty acid synthase attenuates bone loss in ovariectomized mice
  34. AP‐1 and Mitf interact with NFATc1 to stimulate cathepsin K promoter activity in osteoclast precursors
  35. Short Session High Intensity Interval Training and Treadmill Assessment in Aged Mice
  36. Absence of complement factor H alters bone architecture and dynamics
  37. Myeloid-Derived Suppressor Cells at the Intersection of Inflammaging and Bone Fragility
  38. Chronic vitamin D insufficiency impairs physical performance in C57BL/6J mice
  39. Methamphetamine Induces Apoptosis of Microglia via the Intrinsic Mitochondrial-Dependent Pathway
  40. Micro-CT analysis of trabecular parameters gradients in femurs of mice affected by chronic kidney disease
  41. Neuropeptide Y Y2 antagonist treated ovariectomized mice exhibit greater bone mineral density
  42. Sleep Problems and Their Relationship to Maladaptive Behavior Severity in Psychiatrically Hospitalized Children with Autism Spectrum Disorder (ASD)
  43. Verbal Ability and Psychiatric Symptoms in Clinically Referred Inpatient and Outpatient Youth with ASD
  44. Talking About Death or Suicide: Prevalence and Clinical Correlates in Youth with Autism Spectrum Disorder in the Psychiatric Inpatient Setting
  45. High Intensity Interval Training Improves Physical Performance and Frailty in Aged Mice
  46. Problem Behaviors in Autism Spectrum Disorder: Association with Verbal Ability and Adapting/Coping Skills
  47. Predictors of Inpatient Psychiatric Hospitalization for Children and Adolescents with Autism Spectrum Disorder
  48. A mouse model of vitamin D insufficiency: is there a relationship between 25(OH) vitamin D levels and obesity?
  49. Cellular and Molecular Aging
  50. Calciotropic Hormones
  51. Mouse Models of Frailty: an Emerging Field
  52. Statement of Principle
  53. Vitamin D: A Regulator of Metabolism and Inflammation
  54. Resveratrol: Effects on Lipids and Cardiovascular Risk
  55. Do Vitamin D Levels Influence the Risk of Diabetes Mellitus and Play a Role in Healthier Aging?
  56. 3. Impact of Vitamin D on the Aging Population
  57. Retinoic acid inhibits NFATc1 expression and osteoclast differentiation
  58. The Response of Elderly Veterans to Daily Vitamin D3 Supplementation of 2,000 IU: A Pilot Efficacy Study
  59. Cell and Molecular Aging
  60. Treatment for osteoporosis in Australian residential aged care facilities: consensus recommendations for fracture prevention
  61. The cathepsin L gene is a direct target of FOXO1 in skeletal muscle
  62. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand
  63. Vitamin D Supplementation in Older Persons: Benefits and Requirements
  64. Some new food for thought: The role of vitamin D in the mental health of older adults
  65. Calciotropic Hormones
  66. Hypovitaminosis D in the elderly: From bone to brain
  67. ERRATUM
  68. Understanding the Mechanisms of Senile Osteoporosis: New Facts for a Major Geriatric Syndrome
  69. Fat and Inflammaging: A Dual Path to Unfitness in Elderly People?
  70. Functional grouping of osteoclast genes revealed through microarray analysis
  71. AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells
  72. RESPONSE LETTER TO DRS. FISHER AND DAVIS
  73. Osteoporosis in Older People: A Tale of Two Studies (and Three Treatments)
  74. The Regulation of Cathepsin K Gene Expression
  75. RANK ligand and interferon gamma differentially regulate cathepsin gene expression in pre-osteoclastic cells
  76. RANK-L induces the expression of NFATc1, but not of NFκB subunits during osteoclast formation
  77. The role of cathepsin K in normal bone resorption
  78. Molecular mechanisms underlying osteoclast formation and activation
  79. Molecular cloning, expression, and function of osteoclastic calcineurin Aα
  80. Differential effects of interleukin-6 receptor activation on intracellular signaling and bone resorption by isolated rat osteoclasts
  81. Cathepsin K, Osteoclastic Resorption, and Osteoporosis Therapy
  82. Macrophage Colony-Stimulating Factor Suppresses Osteoblast Formation
  83. New Insights into the Regulation of Cathepsin K Gene Expression by Osteoprotegerin Ligand
  84. Cell and Molecular Aging
  85. Transcription of Human Cathepsin B Is Mediated by Sp1 and Ets Family Factors in Glioma
  86. Differentiating agents regulate cathepsin B gene expression in HL-60 cells
  87. Cd38/Adp-Ribosyl Cyclase
  88. Comparative responsiveness of HL-60, HL-60R, and HL-60R+ (LRARSN) cells to retinoic acid, calcitriol, 9 cis-retinoic acid, and sodium butyrate
  89. Cloning, genomic organization, and chromosomal localization of human cathepsin L.
  90. Use of a cloned multidrug resistance gene for coamplification and overproduction of major excreted protein, a transformation-regulated secreted acid protease.
  91. Use of a Cloned Multidrug Resistance Gene for Coamplification and Overproduction of Major Excreted Protein, a Transformation-Regulated Secreted Acid Protease
  92. Cloning and expression of the gene for the major excreted protein of transformed mouse fibroblasts. A secreted lysosomal protease regulated by transformation.
  93. Sequence and expression of the cDNA for MEP (major excreted protein), a transformation-regulated secreted cathepsin
  94. [30] Colony screening of genomic cosmid libraries
  95. Effect of age on the 3,5,3′-tri-iodothyronine-induced increase in sugar uptake in rat thymocytes
  96. Influence of age and sex on the concentrations of thyroid hormone in serum in the rat
  97. Sympathetic Nervous System and Aging in Man
  98. Plasma epinephrine and control of plasma renin activity: possible extrarenal mechanisms
  99. Studies of the human testis
  100. Studies of the Human Testis. III. Effect of Estrogen on Testosterone Formation in Human Testisin Vitro